Pre-Open Stock Movers 03/29: (BOXL) (PRGS) (CELG) Higher; (SGH) (RH) (CHMA) Lower (more...)

March 29, 2019 9:27 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Today's Pre-Open Movers

Boxlight Corporation (NASDAQ: BOXL) 23.4% HIGHER; reported Q4 EPS of ($0.06), $0.11 better than the analyst estimate of ($0.17). Revenue for the quarter came in at $12 million versus the consensus estimate of $11 million. Revenues increased by 125% to $12.0 million; greater than the previously projected $11 million.

Progress Software (NASDAQ: PRGS) 22.2% HIGHER; reported Q1 EPS of $0.50, $0.03 better than the analyst estimate of $0.47. Revenue for the quarter came in at $89.5 million versus the consensus estimate of $87.64 million. Progress Software sees Q2 2019 EPS of $0.55-$0.57, versus the consensus of $0.57. Progress Software sees Q2 2019 revenue of $96-99 million, versus the consensus of $93.22 million. Progress Software sees FY2019 EPS of $2.46-$2.52, versus the consensus of $2.37. Progress Software sees FY2019 revenue of $422-428 million, versus the consensus of $383.42 million.

Marker Therapeutics (NASDAQ: MRKR) 17.7% HIGHER; WBB Securities upgraded from Buy to Strong Buy with a price target of $12.50 (from $5.50).

SMART Global Holdings, Inc. (NASDAQ: SGH) 16.2% LOWER; reported Q2 EPS of $0.77, $0.02 better than the analyst estimate of $0.75. Revenue for the quarter came in at $304.1 million versus the consensus estimate of $317.31 million. SMART Global Holdings, Inc. sees Q3 2019 EPS of $0.34-$0.38, versus the consensus of $0.90. SMART Global Holdings, Inc. sees Q3 2019 revenue of $260-270 million, versus the consensus of $331.6 million.

RH (NYSE: RH) 15.5% LOWER; reported Q4 EPS of $3.00, $0.15 better than the analyst estimate of $2.85. Revenue for the quarter came in at $670.9 million versus the consensus estimate of $686.6 million. RH sees FY2019 EPS of $8.41-$9.08, versus the consensus of $10.13. RH sees FY2019 revenue of $2.585-2.635 billion, versus the consensus of $2.76 billion.

Chiasma, Inc. (Nasdaq: CHMA) 12.9% LOWER; announced that it has commenced an underwritten public offering of its common stock

Oxford Industries (NYSE: OXM) 9.1% LOWER; reported Q4 EPS of $0.99, $0.05 worse than the analyst estimate of $1.04. Revenue for the quarter came in at $298.5 million versus the consensus estimate of $301.84 million. Oxford Industries sees Q1 2019 EPS of $1.15-$1.25, versus the consensus of $1.32. Oxford Industries sees Q1 2019 revenue of $270-280 million, versus the consensus of $285.57 million. Oxford Industries sees FY2019 EPS of $4.45-$4.65, versus the consensus of $4.29. Oxford Industries sees FY2019 revenue of $1.135-1.155 billion, versus the consensus of $1.11 billion.

Eagle Materials (NYSE: EXP) 6.8% HIGHER; Sachem Head is Said to Push for Breakup of Eagle Materials (NYSE: EXP), Said to Want to Sell Frac Sand Unit - Bloomberg

Science Applications Int'l (NYSE: SAIC) 6.7% HIGHER; reported Q4 EPS of $1.17, $0.38 better than the analyst estimate of $0.79. Revenue for the quarter came in at $1.19 billion versus the consensus estimate of $1.17 billion.

Celgene (NASDAQ: CELG) 6.1% HIGHER; Bristol-Myers Squibb (NYSE: BMY) confirmed that ISS recommended voting in favor of the deal.

Viking Therapeutic (NASDAQ: VKTX) 4.9% HIGHER; SVB Leerink upgraded from Market Perform to Outperform with a price target of $21.00 (from $10.00).

Yeti Holdings Inc. (NYSE: YETI) 3.4% LOWER; Morgan Stanley downgraded from Overweight to Equalweight, price target $32.00 (from $26.00).

Wells Fargo & Company (NYSE: WFC) 2.7% HIGHER; announced today that Chief Executive Officer and President Timothy J. Sloan has informed the Companys Board of Directors of his decision to retire from the Company, effective June 30, 2019, and to step down as CEO, president, and Board member effective immediately. The Board has elected C. Allen Parker, who served as the Companys General Counsel, as interim CEO and President (and member of the Board), effective immediately. An external search process will now begin for the Companys new CEO and President.

Apellis Pharmaceuticals (NASDAQ: APLS) 1.9% HIGHER; Baird initiates coverage with a Outperform rating and a price target of $45.00.

lululemon athletica inc. (NASDAQ: LULU) 1% LOWER; agreed to repurchase one million shares of its common stock in a private transaction with funds affiliated with Advent International Corporation (Advent). These shares will be repurchased under the companys $500 million share repurchase authorization and funded with cash on hand. Following this transaction there will be $337 million remaining on the Companys share repurchase authorizations. Advent has also informed lululemon that it has sold an additional four million shares of the companys common stock pursuant to Rule 144. Prior to these sales, Advent owned approximately 10.1 million shares of lululemon common stock.

Sprint Corp. (NYSE: S) 0.9% LOWER; T-Mobile (NASDAQ: TMUS)-Sprint Corp. (NYSE: S) Merger Said to Face Possible Lawsuit by States - Bloomberg

Comcast Corp (NASDAQ: CMCSA) 0.7% LOWER; RBC Capital downgraded from Outperform to Sector Perform with a price target of $42.00 (from $45.00).



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Morgan Stanley, Robert W Baird, RBC Capital, Wells Fargo, Pre-Open Losers, Pre Market Movers, Sachem Head Capital